CEACAM5 and neoplasm: In our study, circulating MDMs in combination with CEA showed a longer lead time to and sensitivity for recurrent CRC than imaging studies and CEA alone in detecting recurrent CRC regardless of the molecular and histological features of the tumor, further supporting the clinical utility of a tumor-agnostic approach.